why choose us

First received: February 23, 2023

Clinical Trial: Curcumin and Retinal Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Bioavailability

Study Type: INTERVENTIONAL


Official Title: Curcumin and Retinal Amyloid-beta Pilot Study

Brief Summary: To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.

Read more